Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| VICAL INC | 50,000 | reported | 21 May 2015 | tx 6+162,179 |
| RIGEL PHARMACEUTICALS INC | 40,000 | reported | 11 May 2016 | tx 23+255,961 |
| ADURO BIOTECH, INC. | 30,000 | reported | 05 May 2020 | tx 6+121,000 |
| ANI PHARMACEUTICALS INC | 25,000 | reported | 30 Mar 2012 | tx 13+280,119 |
| Verastem, Inc. | 17,969 | reported | 12 Jun 2015 | tx 6+86,085 |
| BIOGEN INC. | 13,688 | reported | 17 Jun 2025 | tx 55+98,808−85,422 |
| NEUROCRINE BIOSCIENCES INC | 2,567 | reported | 27 May 2026 | tx 71+435,414−376,912 |
| Neon Therapeutics, Inc. | 0 | reported | 06 May 2020 | tx 5+18,500−82,500 |
| CELL GENESYS INC | 0 | reported | 14 Oct 2009 | tx 27+660,872−1,509,121 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 May 2026 | GRANT_AWARD | NEUROCRINE BIOSCIENCES INC | 2,567 | 0.00 USD | deriv |
| 21 May 2026 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 3,318 | 0.00 USD | |
| 21 May 2026 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 3,318 | 0.00 USD | deriv |
| 02 Sept 2025 | GIFT | NEUROCRINE BIOSCIENCES INC | 1,000 | 0.00 USD | |
| 17 Jun 2025 | GRANT_AWARD | BIOGEN INC. | 2,370 | 0.00 USD | |
| 22 May 2025 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 2,869 | 0.00 USD | |
| 21 May 2025 | GRANT_AWARD | NEUROCRINE BIOSCIENCES INC | 3,318 | 0.00 USD | deriv |
| 22 May 2025 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 2,869 | 0.00 USD | deriv |
| 07 Mar 2025 | SALE | BIOGEN INC. | 8,760 | 150.02 USD | |
| 13 Feb 2025 | SALE | NEUROCRINE BIOSCIENCES INC | 13,831 | 116.69 USD | |
| 04 Nov 2024 | GIFT | NEUROCRINE BIOSCIENCES INC | 2,000 | 0.00 USD | |
| 21 Jun 2024 | GRANT_AWARD | BIOGEN INC. | 1,340 | 0.00 USD | |
| 29 May 2024 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 25,000 | 42.76 USD | |
| 29 May 2024 | SALE | NEUROCRINE BIOSCIENCES INC | 15,000 | 133.47 USD | |
| 29 May 2024 | SALE | NEUROCRINE BIOSCIENCES INC | 25,000 | 133.46 USD | |
| 29 May 2024 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 15,000 | 47.89 USD | |
| 29 May 2024 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 15,000 | 0.00 USD | deriv |
| 29 May 2024 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 25,000 | 0.00 USD | deriv |
| 22 May 2024 | GRANT_AWARD | NEUROCRINE BIOSCIENCES INC | 2,869 | 0.00 USD | deriv |
| 17 May 2024 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 4,199 | 0.00 USD | |
| 17 May 2024 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 4,199 | 0.00 USD | deriv |
| 16 Nov 2023 | GIFT | NEUROCRINE BIOSCIENCES INC | 2,750 | 0.00 USD | |
| 26 Jun 2023 | GRANT_AWARD | BIOGEN INC. | 960 | 0.00 USD | |
| 17 May 2023 | GRANT_AWARD | NEUROCRINE BIOSCIENCES INC | 4,199 | 0.00 USD | deriv |
| 15 Nov 2022 | GIFT | BIOGEN INC. | 695 | 0.00 USD |
1 purchase reported after at least 12 months of silence — most recent on 26 Dec 2014.